Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $86
Benzinga Newsdesk 20 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price target from $94 to $86.
Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price target from $94 to $86.